Skip to content

Multicenter registry study on treatment of acute ischemic stroke with green channel

Multicenter registry study on treatment of acute ischemic stroke with green channel

Status
Recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-HIC-17011532
Enrollment
Unknown
Registered
2017-05-31
Start date
2017-06-01
Completion date
Unknown
Last updated
2017-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute ischemic stroke

Interventions

Sponsors

Shanghai Changhai hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) To be diagnosed as acute ischemic stroke clinically, and neurological deficits are caused; (2) intravenous thrombolysis or endovascular recanalization is required to enter the green channel; (3) informed consent of the patient or family, and willing to cooperate with follow-up.

Exclusion criteria

Exclusion criteria: 1, absolute exclusion criteria: (1) significant head trauma or stroke history in recent March; (2) arterial puncture of non compression part within 7 days; (3) history of intracranial hemorrhage; (4) intracranial neoplasm, arteriovenous malformation, or aneurysm; (5) recent intracranial or intraspinal surgery history; (6) elevated blood pressure (systolic pressure >185mmHg, diastolic pressure >110mmHg); (7) active internal bleeding; (8) acute bleeding tendency, including platelet count, 1.7 or PT>15s; (11) the immediate use of direct thrombin inhibitors or direct Xa factor inhibitors, and related indicators increased (12) blood sugar 80 years old; (2) NIHSS>25 minutes; (3) use oral anticoagulant, regardless of INR value; (4) there was a history of diabetes and ischemic stroke; 3, relative exclusion criteria: (1) mild or spontaneous improvement in stroke symptoms; (2) pregnancy; (3) neurological impairment after epileptic seizures; (4) major surgery or severe trauma in the past 14 days; (5) gastrointestinal bleeding or urinary tract bleeding in the recent (21 days) period; (6) recent myocardial infarction (within 3 months).

Design outcomes

Primary

MeasureTime frame
favorable outcome;neurological improvement within 24 hours;rate of symptomatic intracranial hemorrhage;door to needle time;ischemic time;

Countries

China

Contacts

Public ContactZhang Congxin

Shanghai Changhai hospital

zhangyongwei@163.com+86 18602190767

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026